{
  "docId": "019de071-1bdd-70bb-9c61-980d0c38b663",
  "docSlug": "a4792f18c57ea3f4ba27e696a63520de",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.4148858,
  "pageNumber": 6,
  "pageCount": 40,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 7,
  "notes": "The slide uses a circular timeline graphic to emphasize the 3rd consecutive plenary session achievement.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/6",
  "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663",
  "deckJsonHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663.json",
  "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.02,
        "y": 0.68
      },
      "kind": "diagram",
      "text": "2019 POLO, 2020 ADAURA, 2021 OlympiA",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f516eda-c732-42de-970e-3dbb1bbdda27",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.65,
        "y": 0.2
      },
      "kind": "list",
      "text": "Data highlights: Lynparza (Olympia), Calquence (ELEVATE-TN/RR), Imfinzi (PACIFIC), Enhertu/datopotamab deruxtecan",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "78a1942b-6176-4bc7-8230-90747f17a1bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.25,
        "x": 0.3,
        "y": 0.2
      },
      "kind": "list",
      "text": "90 abstracts with 74 presentations: 1 plenary, 12 oral, 14 poster discussions, 47 posters, 16 abstracts",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ca9b315d-19fa-4269-aee3-a55dccc3f61f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.3,
        "y": 0.8
      },
      "kind": "source-note",
      "text": "Source: ASCO 2021 accepted abstracts. 24 additional presentations at ASCO 2021 will feature AstraZeneca medicines and potential new medicines but were not supported by AstraZeneca.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f32f8c61-be4e-48be-a11e-a9a124243303",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.2,
        "x": 0.05,
        "y": 0.6
      },
      "kind": "title",
      "text": "3rd plenary session in a row",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c7f14b1-b258-4867-976a-160da4f49fea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "title",
      "text": "ASCO 2021: Another strong presence",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb776c26-b18c-4a67-a39c-d1f60d754342",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "bc39bc86-f86f-4b73-b196-3e8c48bc4893",
      "evidence": "Data highlights: Lynparza (Olympia), Calquence (ELEVATE-TN/RR), Imfinzi (PACIFIC), Enhertu/datopotamab deruxtecan",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "013b22ce-efb3-41b5-b943-22ca3f13c25d",
      "evidence": "The slide uses bulleted lists to organize key metrics and data highlights.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 4,
      "beatId": "7159cdd6-69bd-490b-9adf-e3d02ec358ec",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The document highlights the need for innovation in oncology and AstraZeneca's position in the market.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 4,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "cb0be392-a7b1-4037-8b53-e6e6f869695a",
      "evidence": "The document highlights several trends and patterns in oncology, including the importance of combinations and new Phase III medicines.",
      "position": 0,
      "objective": "What are the key trends and patterns in oncology?",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.6,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}